Sec. 101. Enhanced fentanyl surveillance
338 words·~2 min read·
/bill/117/hr/2366/ih/section-101·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Director of the Centers for Disease Control and Prevention shall enhance the drug surveillance program of the Centers by— expanding such surveillance program to include all 50 States, the territories of the United States, and all Tribes and Tribal organizations; increasing and accelerating the collection of data on fentanyl, fentanyl-related substances, other synthetic opioids, and new emerging drugs of abuse, including related overdose data from medical examiners and drug treatment admissions and information regarding drug seizures; and utilizing available and emerging information on fentanyl, fentanyl-related substances, other synthetic opioids, and new emerging drugs of abuse, including information from— the National Drug Early Warning System;
State and local public health authorities; Federal, State, and local public health laboratories; and drug seizures by Federal, State, and local law enforcement agencies, including information from the National Seizure System and the National Forensic Laboratory Information System of the Drug Enforcement Administration. The Director of the Centers for Disease Control and Prevention shall share the information collected through the drug surveillance program of the Centers with entities including the Office of National Drug Control Policy, State and local public health agencies, and Federal, State, and local law enforcement agencies.
Each Federal law enforcement agency shall report information on all drug seizures by that agency to the Drug Enforcement Administration for inclusion in the National Seizure System. Not later than 2 years after the date of enactment of this Act, the Comptroller General of the United States shall— publish a report analyzing how Federal agencies can improve their collection, reporting, sharing, and analytic use of drug seizure data across Federal agencies and with State and local governments; and include in such report an analysis of how well available data on drug seizures can measure progress toward reducing drug trafficking into and within the country, as outlined in strategies such as the National Drug Control Strategy of the Office of National Drug Control Policy.
To carry out this section, there is authorized to be appropriated $125,000,000 for each of fiscal years 2022 through 2026.